TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator (NAO), with scale operations in both Canada and the US, TerrAscend participates in the medical and legal adult use markets across these jurisdictions. TerrAscend operates a number of synergistic businesses, including Ilera Healthcare, Pennsylvania’s premier medical marijuana cultivator, processor and dispenser; The Apothecarium, an award-winning cannabis dispensary with several retail locations in California; Valhalla Confections, a manufacturer of premium cannabis-infused edibles; and Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products. TerrAscend holds a cultivation permit in the State of New Jersey and is pending approval for a vertically integrated medical cannabis operation with the ability to operate up to 3 Alternative Treatment Centers. Additionally, TerrAscend holds a Medical Cannabis Processor License in the State of Utah.
TerrAscend Corp. (TER)
May 2, 2017
The common shares of TerrAscend Corp. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com
TerrAscend is a vertically integrated company that is focused on the production, sale and distribution of cannabis and its derivatives for the medical market. TerrAscend’s wholly-owned subsidiary, Solace Health Inc., is in the final stage of its application for licencing under the Access to Cannabis for Medical Purposes Regulations.